secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2021-08-26T23:59:59+00:00
Accession:  0001104659-21-109803
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Q2 commercial revenue $5.7M (+135% YoY); full-year outlook at least $24M
--------------------------------------------------------------------------------

- Q2 total revenue $6.1M vs $2.6M YoY; net loss ($11.8M) vs ($9.3M) YoY.
- Placed 8 new systems (cumulative 103); validated 11 systems (cumulative 63).
- Sold one-millionth consumable since Growth Direct commercial launch.
- Completed IPO in July 2021: ~9M shares sold, $165.3M net proceeds; pro forma cash ~$260M.
- Full-year 2021 commercial revenue guidance: at least $24.0M (≥70% YoY growth).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000110465921109803/0001104659-21-109803-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000110465921109803/tm2125995d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-109803

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer